Agoracom Logo
sign in
sign in
register
Rules
Sign in with Facebook
Sign in with Linkedin
Forgot your username or password? Recover it here
Not a member yet? Register
Didn't receive confirmation instructions? Resend
  • INVESTORS
    • My Home
    • Small Cap Marketplace
    • Broadcast Center
    • Request New Hub
    • Quick Tips
    • Ratings & Ranks
  • PUBLIC COMPANIES
    • Investor Relations
    • Success Stories
    • Clients
    • Testimonials
    • Contact
  • Conferences
  • About us
docepg
docepg
Follow
Rank: Vice President [?]
Points: 782 [?]
Votes: 37 Score: 3.2 [?]
Your Vote:
Please Log In to Vote
profile Post History
docepg's Recent Posts
Title Rating Company Posted on ▲
Re: roller-coaster 2 Mosaic ImmunoEngineering Inc. Oct 23, 2009 01:23PM
Notes from SHM in 2008 4 Mosaic ImmunoEngineering Inc. Jan 29, 2010 11:04AM
Notes from SHM in 2007 4 Mosaic ImmunoEngineering Inc. Jan 29, 2010 11:05AM
When asking questions to company 4 Mosaic ImmunoEngineering Inc. Nov 18, 2010 11:38AM
Re: When asking questions to company-litigators..... 19 Mosaic ImmunoEngineering Inc. Nov 19, 2010 10:45AM
Transparency 2 Mosaic ImmunoEngineering Inc. Feb 04, 2011 11:43AM
Re: Shareholder Meeting Breakfast Mixer 9 Mosaic ImmunoEngineering Inc. Feb 08, 2012 11:26AM
SHM 18 Mosaic ImmunoEngineering Inc. Feb 10, 2012 05:28PM
Re: SHM 2 Mosaic ImmunoEngineering Inc. Feb 10, 2012 07:48PM
SHM. 5 Mosaic ImmunoEngineering Inc. Feb 11, 2012 10:13AM
RE: Johnson stock remarks 6 Mosaic ImmunoEngineering Inc. Feb 13, 2012 11:51AM
Re: Best and Worst from Shareholder Meeting re to 350 Millions Mosaic ImmunoEngineering Inc. Feb 13, 2012 12:51PM
Re: ASM notes 12 Mosaic ImmunoEngineering Inc. Apr 30, 2013 06:23PM
agoracom
Follow us on: twitter facebook youtube
  • Privacy Policy
  • Terms and Conditions
  • Contact
  • Help

Log in to Agoracom

Sign in with Facebook
Sign in with Linkedin
Forgot your username or password? Recover it here
Not a member yet? Register
Didn't receive confirmation instructions? Resend
Contact Us
Speak with an Agoracom representative today.